Association of Mood With Risk for Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Mood DisordersHypertensionOverweight and ObesityVascular StiffnessSleepElevated Blood Pressure
Interventions
DIAGNOSTIC_TEST

Cardiovascular Assessments

Participants will undergo the following cardiovascular assessments: 24-hour blood pressure monitoring, arterial stiffness measurements, endothelial function measurements.

DIAGNOSTIC_TEST

Actigraphy

Participants will wear an actigraph device for 7 days to measure participant's activity and sleep

DIAGNOSTIC_TEST

Laboratory assessments

Participants will provide blood and urine samples for laboratory assessments.

BEHAVIORAL

Emotional/ Behavioural assessments

Emotional /Behavioral well being will be determined by questionnaires: Pediatrics Adverse Childhood Experiences Questionnaire (ACEs Q), Childrens Emotion Management Scale Questionnaire (CEMS) and Behavior Assessment System for Children (BASC)

Trial Locations (1)

21287

Johns Hopkins School of Medicine Division of Pediatric Nephrology, Baltimore

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Johns Hopkins University

OTHER

NCT04298944 - Association of Mood With Risk for Atherosclerosis | Biotech Hunter | Biotech Hunter